{"schema_version":"secwatch.filing_event.v1","accession":"0001544784-22-000009","form_type":"8-K","ticker":"XLO","cik":"0001840233","company_name":"Xilio Therapeutics, Inc.","filed_at":"2022-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.630295+00:00","generated_at":"2026-06-20T23:36:00.927610+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Xilio Therapeutics VP and principal accounting officer Edward C. English resigns effective Jan 31, 2023","bullets":["Edward C. English notified his resignation as VP, finance, accounting, treasury, and principal accounting officer.","Departure effective January 31, 2023, to pursue other opportunities.","No successor or interim replacement disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001544784-22-000009","json":"https://secwatch.observer/filing/0001544784-22-000009.json","markdown":"https://secwatch.observer/filing/0001544784-22-000009.md","text":"https://secwatch.observer/filing/0001544784-22-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840233/000154478422000009/0001544784-22-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840233/000154478422000009/xlo-20221219x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:36:00.927610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b55dd764f7","claim":"Edward C. English resigned as vice president, finance, accounting and treasury and principal accounting officer at Xilio Therapeutics, Inc..","evidence_excerpt":"On December 19, 2022, Edward C. English notified Xilio Therapeutics, Inc. (the “Company”) of his decision to resign as vice president, finance, accounting and treasury and principal accounting officer of the Company, effective January 31, 2023, to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840233/000154478422000009/0001544784-22-000009-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"vice president, finance, accounting and treasury and principal accounting officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}